US Patent Issued to ABSCI on Nov. 18 for "TL1A associated antibody compositions and methods of use" (Greek, American Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,370, issued on Nov. 18, was assigned to ABSCI Corp. (Vancouver, Wash.).

"TL1A associated antibody compositions and methods of use" was invented by Daniele Biasci (Athens, Greece), Sharrol Bachas (Vancouver, Wash.), Amir Shanehsazzadeh (Vancouver, Wash.), Vincent Blay (Vancouver, Wash.), Matthew Waugh (Vancouver, Wash.), Simon Levine-Gottreich (Vancouver, Wash.), Anand Sastry (Vancouver, Wash.), Douglas Ganini Da Silva (Vancouver, Wash.), Matthew McPartlon (Vancouver, Wash.), Emily Gage (Vancouver, Wash.) and David Spencer (Vancouver, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure herein relates to the development and production ...